Elemy, formerly known as Sprout Therapy, is a B2B2C platform helping healthcare payors provide their members access to in-home pediatric care for ongoing chronic & behavioral challenges, including child autism.
Elemy leverages technology to deliver a better experience to families, providers, and healthcare payors.
Elemy was founded in 2019 by Yury Yakubchyk and Michael Ragheb. The company is headquartered in San Francisco, California.
Elemy offers a tech-enabled platform for personalized care. Elemy’s clinicians create customized treatment plans that can be administered both online and in-home, where children are more comfortable and have fewer distractions.
Elemy's platform simplifies the onboarding process and more quickly pairing expert clinicians with patients to educe the patient onboarding process to as little as 12 weeks from an industry average of six months to two years—giving families back time that is critical for achieving the best possible outcomes for their children, according to the company.
Elemy works with Medicaid programs in states including Florida, Georgia and California, as well as insurance providers. The company is already delivering care in 14 states.
Elemy is backed by General Catalyst, SoftBank Vision Fund 2, Founders Fund, Goodwater Capital, SignalFire, Premji Invest, e.ventures, 8VC, Felicis Ventures, Amity Ventures, and others. The company raised $219M in Series B round on Oct 08, 2021. This brings Elemy's total funding to $323M to date. The latest round valued Elemy at $1.15B post-money.